HK1111622A1 - Dried milled granulate and methods - Google Patents
Dried milled granulate and methodsInfo
- Publication number
- HK1111622A1 HK1111622A1 HK08105730.6A HK08105730A HK1111622A1 HK 1111622 A1 HK1111622 A1 HK 1111622A1 HK 08105730 A HK08105730 A HK 08105730A HK 1111622 A1 HK1111622 A1 HK 1111622A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- methods
- granulate
- dried milled
- milled granulate
- particle size
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Processing Of Solid Wastes (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Glanulating (AREA)
- Materials Applied To Surfaces To Minimize Adherence Of Mist Or Water (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71258005P | 2005-08-30 | 2005-08-30 | |
US11/507,240 US20070048373A1 (en) | 2005-08-30 | 2006-08-21 | Dried milled granulate and methods |
PCT/US2006/033779 WO2007027720A2 (fr) | 2005-08-30 | 2006-08-29 | Granule broye seche et procedes associes |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1111622A1 true HK1111622A1 (en) | 2008-08-15 |
Family
ID=37804492
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08105730.6A HK1111622A1 (en) | 2005-08-30 | 2008-05-23 | Dried milled granulate and methods |
HK10111702.4A HK1145146A1 (en) | 2005-08-30 | 2010-12-15 | Dried milled granulate and methods |
HK12100538.5A HK1160010A1 (en) | 2005-08-30 | 2012-01-17 | Dried milled granulate and methods |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK10111702.4A HK1145146A1 (en) | 2005-08-30 | 2010-12-15 | Dried milled granulate and methods |
HK12100538.5A HK1160010A1 (en) | 2005-08-30 | 2012-01-17 | Dried milled granulate and methods |
Country Status (12)
Country | Link |
---|---|
US (1) | US20070048373A1 (fr) |
EP (3) | EP2359811B1 (fr) |
JP (1) | JP5144519B2 (fr) |
AT (2) | ATE539739T1 (fr) |
CA (1) | CA2621079C (fr) |
DE (1) | DE602006012503D1 (fr) |
DK (1) | DK2198855T3 (fr) |
ES (3) | ES2398637T3 (fr) |
HK (3) | HK1111622A1 (fr) |
MX (1) | MX2008002779A (fr) |
PT (1) | PT2198855E (fr) |
WO (1) | WO2007027720A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
US7485319B2 (en) * | 2003-07-25 | 2009-02-03 | Warner Chilcott Company, Inc. | Doxycycline metal complex in a solid dosage form |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
US7883039B2 (en) * | 2007-02-27 | 2011-02-08 | Collette Nv | Continuous granulating and drying apparatus including measurement units |
US8173169B2 (en) * | 2007-07-11 | 2012-05-08 | Hikma Pharmaceuticals | Formulation and process for the preparation of modafinil |
CN102639118B (zh) | 2009-07-22 | 2015-07-29 | 格吕伦塔尔有限公司 | 氧化稳定的抗干扰剂型 |
ES2668203T3 (es) * | 2009-12-02 | 2018-05-17 | Adare Pharmaceuticals S.R.L. | Microcápsulas de fexofenadina y composiciones que las contienen |
TR201000688A2 (tr) * | 2010-01-29 | 2011-08-22 | B�Lg�� Mahmut | Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar. |
FR2959130A1 (fr) * | 2010-04-21 | 2011-10-28 | Sanofi Aventis | Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant. |
JP6133009B2 (ja) * | 2010-08-11 | 2017-05-24 | 協和発酵キリン株式会社 | トピラマート顆粒 |
CN103269688A (zh) | 2010-09-02 | 2013-08-28 | 格吕伦塔尔有限公司 | 包含无机盐的抗破碎剂型 |
TR201009396A2 (tr) * | 2010-11-11 | 2012-05-21 | Bi̇lgi̇ç Mahmut | Desloratadin granüller |
KR101380836B1 (ko) * | 2011-01-18 | 2014-04-09 | 한국기계연구원 | 상온진공과립분사 공정을 위한 취성재료 과립 및 이를 이용한 코팅층의 형성방법 |
JP5830412B2 (ja) * | 2011-03-02 | 2015-12-09 | ライオン株式会社 | 水難溶性薬物と賦形剤との粉砕物の製造方法、造粒粒子の製造方法、錠剤の製造方法 |
WO2013017242A1 (fr) | 2011-07-29 | 2013-02-07 | Grünenthal GmbH | Comprimé anti-manipulation permettant une libération immédiate de médicament |
NO2736495T3 (fr) | 2011-07-29 | 2018-01-20 | ||
AR090695A1 (es) | 2012-04-18 | 2014-12-03 | Gruenenthal Gmbh | Forma de dosificacion farmaceutica resistente a la adulteracion y resistente a la liberacion inmediata de la dosis |
WO2014207769A1 (fr) | 2013-06-27 | 2014-12-31 | Mylan Laboratories Ltd | Procédé pour la préparation de népafénac |
KR20160031526A (ko) | 2013-07-12 | 2016-03-22 | 그뤼넨탈 게엠베하 | 에틸렌-비닐 아세테이트 중합체를 함유하는 템퍼 내성 투여형 |
JP6480936B2 (ja) * | 2013-11-26 | 2019-03-13 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | クライオミリングによる粉末状医薬組成物の調製 |
CA2998259A1 (fr) | 2015-09-10 | 2017-03-16 | Grunenthal Gmbh | Protection contre un surdosage par voie orale a l'aide de formulations a liberation immediate dissuasives d'abus |
MX2016013830A (es) * | 2015-10-27 | 2017-05-10 | Shinetsu Chemical Co | Eter de celulosa porosa no ionico soluble en agua que tiene excelente solubilidad y metodo para producir el mismo. |
US20220362191A1 (en) * | 2021-05-12 | 2022-11-17 | Spectrix Therapeutics, LLC | Compositions and methods |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5234957A (en) * | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
IL92343A0 (en) * | 1988-12-20 | 1990-07-26 | Gist Brocades Nv | Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them |
US5178878A (en) * | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
AU5140893A (en) * | 1992-09-30 | 1994-04-26 | Ascent Pharmaceuticals, Inc. | Calcium polycarbophil sprinkle |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US6077533A (en) * | 1994-05-25 | 2000-06-20 | Purdue Pharma L.P. | Powder-layered oral dosage forms |
US6039275A (en) * | 1996-07-04 | 2000-03-21 | Holland Sweetener Company V.O.F. | Aspartame powders for powder mixtures |
ES2296331T3 (es) * | 1997-04-01 | 2008-04-16 | Cima Labs Inc. | Envase de tipo blister y comprimido envasado. |
US6024981A (en) * | 1997-04-16 | 2000-02-15 | Cima Labs Inc. | Rapidly dissolving robust dosage form |
JPH1121236A (ja) * | 1997-07-01 | 1999-01-26 | Ohara Yakuhin Kogyo Kk | ロキソプロフェン・ナトリウム固形製剤 |
US6387410B1 (en) * | 1998-09-10 | 2002-05-14 | Norton Healthcare Ltd | Anti-inflammatory pharmaceutical formulations |
US6740341B1 (en) * | 1998-11-25 | 2004-05-25 | Cima Labs Inc. | Taste masking rapid release coating system |
DE19859636A1 (de) * | 1998-12-23 | 2000-06-29 | Hexal Ag | Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff |
PT1207860E (pt) * | 1999-09-02 | 2008-01-24 | Nostrum Pharmaceuticals Inc | Formulação de peletes de libertação controlada |
ES2281527T3 (es) * | 2001-05-25 | 2007-10-01 | Cephalon, Inc. | Formulaciones farmaceuticas solidas que comprenden modafinilo. |
US7323192B2 (en) * | 2001-09-28 | 2008-01-29 | Mcneil-Ppc, Inc. | Immediate release tablet |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
US6827946B2 (en) * | 2001-12-05 | 2004-12-07 | Collegium Pharmaceutical, Inc. | Compositions containing both sedative and non-sedative antihistamines |
US20050065183A1 (en) * | 2003-07-31 | 2005-03-24 | Indranil Nandi | Fexofenadine composition and process for preparing |
US7207505B2 (en) * | 2004-06-04 | 2007-04-24 | Bender Martin P | Method for producing small granules |
-
2006
- 2006-08-21 US US11/507,240 patent/US20070048373A1/en not_active Abandoned
- 2006-08-29 WO PCT/US2006/033779 patent/WO2007027720A2/fr active Application Filing
- 2006-08-29 EP EP11157456A patent/EP2359811B1/fr active Active
- 2006-08-29 EP EP10001313A patent/EP2198855B1/fr active Active
- 2006-08-29 CA CA2621079A patent/CA2621079C/fr active Active
- 2006-08-29 ES ES11157456T patent/ES2398637T3/es active Active
- 2006-08-29 EP EP06813925A patent/EP1919454B1/fr active Active
- 2006-08-29 MX MX2008002779A patent/MX2008002779A/es active IP Right Grant
- 2006-08-29 AT AT10001313T patent/ATE539739T1/de active
- 2006-08-29 DK DK10001313.5T patent/DK2198855T3/da active
- 2006-08-29 DE DE602006012503T patent/DE602006012503D1/de active Active
- 2006-08-29 JP JP2008529209A patent/JP5144519B2/ja active Active
- 2006-08-29 ES ES10001313T patent/ES2379333T3/es active Active
- 2006-08-29 PT PT10001313T patent/PT2198855E/pt unknown
- 2006-08-29 ES ES06813925T patent/ES2339979T3/es active Active
- 2006-08-29 AT AT06813925T patent/ATE458475T1/de not_active IP Right Cessation
-
2008
- 2008-05-23 HK HK08105730.6A patent/HK1111622A1/xx unknown
-
2010
- 2010-12-15 HK HK10111702.4A patent/HK1145146A1/xx unknown
-
2012
- 2012-01-17 HK HK12100538.5A patent/HK1160010A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ES2379333T3 (es) | 2012-04-25 |
HK1160010A1 (en) | 2012-08-10 |
EP2359811B1 (fr) | 2012-11-14 |
US20070048373A1 (en) | 2007-03-01 |
EP1919454B1 (fr) | 2010-02-24 |
DE602006012503D1 (de) | 2010-04-08 |
WO2007027720A3 (fr) | 2007-08-02 |
EP2198855A1 (fr) | 2010-06-23 |
MX2008002779A (es) | 2008-04-07 |
JP2009505798A (ja) | 2009-02-12 |
CA2621079C (fr) | 2014-02-18 |
ATE539739T1 (de) | 2012-01-15 |
ES2398637T3 (es) | 2013-03-20 |
EP1919454A2 (fr) | 2008-05-14 |
ES2339979T3 (es) | 2010-05-27 |
EP2359811A1 (fr) | 2011-08-24 |
CA2621079A1 (fr) | 2007-03-08 |
PT2198855E (pt) | 2012-03-19 |
JP5144519B2 (ja) | 2013-02-13 |
EP2198855B1 (fr) | 2012-01-04 |
WO2007027720A2 (fr) | 2007-03-08 |
HK1145146A1 (en) | 2011-04-08 |
DK2198855T3 (da) | 2012-04-02 |
ATE458475T1 (de) | 2010-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1160010A1 (en) | Dried milled granulate and methods | |
ATE525441T1 (de) | Pigmentgranulate | |
EP1913776A4 (fr) | Protection d'un contenu a diffusion continue elementaire | |
EP1747819A4 (fr) | Classificateur, broyeur vertical doté du classificateur, et appareil de chaudière à charbon doté du broyeur vertical | |
ZA200900204B (en) | Substituted piperidines that increase P53 activity and the uses thereof | |
ZA200803048B (en) | Microangiopathy treatment and prevention | |
EP1894634A4 (fr) | Pulvérisateur électrostatique et soufflante l'utilisant | |
SG113519A1 (en) | Sorting particles | |
EP1723238A4 (fr) | Virus oncolytiques modifies | |
GB2445638B (en) | Granular solid wax particle | |
EP1731540A4 (fr) | Particule polymere | |
EP1929010A4 (fr) | Particules polymeriques et leurs applications | |
EP1722639A4 (fr) | Composites secs proteges | |
IL184834A0 (en) | Compositions and methods for the manufacture thereof | |
EP1951197A4 (fr) | Processus de regulation de la dimension de particule | |
EP1881195A4 (fr) | Outil permettant de prevenir l'effet vortex | |
EP2005968A4 (fr) | Particule nanocomposite | |
SI1955056T1 (sl) | Detektor delcev | |
EP1918258A4 (fr) | Procédé de production de particules inorganiques sphériques | |
GB0510461D0 (en) | Assay particles | |
EP1960510A4 (fr) | Mutant d'aminase 5'-xmp reagissant specifiquement a l'ammoniac | |
ZA200707436B (en) | Particle and preparation containing the particle | |
GB0519148D0 (en) | Improved particle metrology | |
GB0521436D0 (en) | The type G-23 - donor share certificate program system and project - series 1.0 | |
GB0522684D0 (en) | Oncolytic viruses |